Skip to content

Clinical trials

Phase 3 Coronavirus Infections trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronavirus Infections Phase: Phase 3 Country / region: Canada Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
202011
20211
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated5
Recruiting2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Université de Sherbrooke2
AstraZeneca1
Corvus Pharmaceuticals, Inc.1
McGill University Health Centre/Research Institute of the McGill University Health Centre1
Megan Landes1
ModernaTX, Inc.1
Montreal Heart Institute1
Pfizer1
Population Health Research Institute1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronavirus Infections16
COVID-1912
Severe Acute Respiratory Syndrome5
Respiratory Distress Syndrome3
Virus Diseases3
Infections2
Lung Diseases2
Respiratory Tract Infections2
Acute Kidney Injury1
Coronaviridae Infections1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.